首页|复杂制剂开发过程合规性探讨

复杂制剂开发过程合规性探讨

扫码查看
目的 为复杂制剂开发过程合规性建设提出建议,推动复杂制剂开发过程中的合理性和规范性.方法 梳理了复杂制剂开发过程特点及难点,结合药品生产质量管理规范(GMP)技术要求和核查关注要点,分析复杂制剂开发过程常见不合规情形,提出合规建议.结果 复杂制剂的开发常受限于辅料、器械、制药设备等,对人员素质要求较高,多采用创新的生产工艺或在常规生产工艺中引入新的技术,且制备工艺复杂、质量控制参数多、常需要委托生产或委托检验等.部分复杂制剂持有人是新兴的高新技术企业,缺乏全生命周期质量管理经验,企业在关键人员培训、辅料使用及变更、设备验证、工艺变更、技术转移、偏差管理、委托研究、数据可靠性等方面常会出现不足.结论 基于复杂制剂产品开发过程特点和注册核查重点,申请人需要加强质量管理,确保复杂制剂的开发过程科学、合理、规范,保障复杂制剂安全性和质量可控性.
Discussion on Compliance of Complex Formulation Development Process
OBJECTIVE To provide suggestions for the compliance construction of complex formulation development processes,and promote the rationality and standardization of complex formulation development processes.METHODS Sorted out the charac-teristics and difficulties of the complex formulation development process,combined with the GMP technical requirements and verifica-tion focus,analyzed the common non-compliance situations in the complex formulation development process,and proposed compli-ance suggestions.RESULTS The development of complex formulations is often limited to excipients,instruments,pharmaceutical equipment,etc.,with high requirements for personnel quality.Innovative production processes are often adopted or new technologies are introduced into conventional production processes,and the preparation process is complex with multiple quality control parame-ters,often requiring commissioned production or inspection.Some holders of complex formulations are emerging high-tech enterprises that lack experience in full lifecycle quality management.Enterprises often experience deficiencies in key personnel training,auxilia-ry material use and changes,equipment validation,process changes,technology transfer,deviation management,commissioned re-search,and data reliability.CONCLUSION Based on the characteristics of the complex formulation product development process and the key points of registration verification,the applicant needs to strengthen quality management,ensure the scientific,reasona-ble,and standardized development process of complex formulations,and ensure the safety and quality controllability of complex for-mulations.

complex formulationquality assurancedevelopment processcompliance

宋波、黄莺、李珊

展开 >

国家药品监督管理局食品药品审核查验中心,北京 100044

复杂制剂 质量管理 开发过程 合规性

2024

中国药学杂志
中国药学会

中国药学杂志

CSTPCD北大核心
影响因子:0.957
ISSN:1001-2494
年,卷(期):2024.59(8)
  • 16